Cerys J. Evans and Lubica Dudakova contributed equally to this work.
The purpose of this study was to identify the genetic cause and describe the clinical phenotype of Schnyder corneal dystrophy (SCD) in six unrelated probands.
We identified two white Czech, two white British and two South Asian families with a clinical diagnosis of SCD. Ophthalmic assessment included spectral domain optical coherence tomography (SD-OCT) of one individual with advanced disease, and SD-OCT and confocal microscopy of a child with early stages of disease. UBIAD1 coding exons were amplified and Sanger sequenced in each proband. A fasting serum lipid profile was measured in three probands. Paternity testing was performed in one family.
A novel heterozygous c.527G>A; p.(Gly176Glu) mutation in UBIAD1 was identified in one Czech proband. In the second Czech proband, aged 6 years when first examined, a previously described de novo heterozygous c.289G>A; p.(Ala97Thr) mutation was found. Two probands of South Asian descent carried a known c.305G>A; p.(Asn102Ser) mutation in the heterozygous state. Previously reported heterozygous c.361C>T; p.(Leu121Phe) and c.308C>T; p.(Thr103Ile) mutations were found in two white British families. Although crystalline deposits were present in all probands the affected area was small in some individuals. Corneal arcus and stromal haze were the most prominent phenotypical feature in two probands. In the Czech probands, SD-OCT confirmed accumulation of reflective material in the anterior stroma. Crystalline deposits were visualized by confocal microscopy. Mild dyslipidemia was found in all three individuals tested.
Although de novo occurrence of mutations in UBIAD1 is extremely rare, SCD should be considered in the differential diagnosis of bilateral corneal haze and/or crystal deposition, especially in children.
Weiss JS, Kruth HS, Kuivaniemi H, Tromp G, White PS, Winters RS, et al. Mutations in the UBIAD1 gene on chromosome short arm 1, region 36, cause Schnyder crystalline corneal dystrophy. Invest Ophthalmol Vis Sci. 2007;48:5007–12. CrossRef
Weiss JS, Moller HU, Aldave AJ, Seitz B, Bredrup C, Kivelä T, et al. IC3D classification of corneal dystrophies--edition 2. Cornea. 2015;34:117–59. CrossRef
Hoang-Xuan T, Pouliquen Y, Gasteau J. Schnyder's crystalline dystrophy. II. Association with genu valgum. J Fr Ophtalmol. 1985;8:743–7. PubMed
Orr A, Dube MP, Marcadier J, Jiang H, Federico A, George S, et al. Mutations in the UBIAD1 gene, encoding a potential prenyltransferase, are causal for Schnyder crystalline corneal dystrophy. PLoS One. 2007;2:e685. CrossRef
Li W. Bringing bioactive compounds into membranes: the UbiA superfamily of intramembrane aromatic prenyltransferases. Trends Biochem Sci. 2016;41:356–70. CrossRef
Mahelkova G, Filous A, Odehnal M, Cendelin J. Corneal changes assessed using confocal microscopy in patient with unilateral buphthalmos. Invest Ophthalmol Vis Sci. 2013;54:4048–53. CrossRef
Choi Y, Sims GE, Murphy S, Miller JR, Chan AP. Predicting the functional effect of amino acid substitutions and indels. PLoS One. 2012;7:e46688. CrossRef
Calabrese R, Capriotti E, Fariselli P, Martelli PL, Casadio R. Functional annotations improve the predictive score of human disease-related mutations in proteins. Hum Mutat. 2009;30:1237–44. CrossRef
Li B, Krishnan VG, Mort ME, Xin F, Kamati KK, Cooper DN, et al. Automated inference of molecular mechanisms of disease from amino acid substitutions. Bioinformatics. 2009;25:2744–50. CrossRef
Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4:1073–81. CrossRef
Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248–9. CrossRef
Schwarz JM, Rodelsperger C, Schuelke M, Seelow D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods. 2010;7:575–6. CrossRef
Evans CJ, Liskova P, Dudakova L, Hrabcikova P, Horinek A, Jirsova K, et al. Identification of six novel mutation in ZEB1 and description of the associated phenotypes in patients with posterior polymorphous corneal dystrophy 3. Ann Hum Genet. 2015;79:1–9. CrossRef
Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285–91. CrossRef
Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285:2486–97. CrossRef
American Academy of Pediatrics. Committee on nutrition. Cholesterol in childhood. Pediatrics. 1998;101:141–7. CrossRef
Nickerson ML, Bosley AD, Weiss JS, Kostiha BN, Hirota Y, Brandt W, et al. The UBIAD1 prenyltransferase links menaquinone-4 [corrected] synthesis to cholesterol metabolic enzymes. Hum Mutat. 2013;34:317–29. CrossRef
Weiss JS, Kruth HS, Kuivaniemi H, Tromp G, Karkera J, Mahurkar S, et al. Genetic analysis of 14 families with Schnyder crystalline corneal dystrophy reveals clues to UBIAD1 protein function. Am J Med Genet A. 2008;146A:271–83. CrossRef
Nickerson ML, Kostiha BN, Brandt W, Fredericks W, Xu KP, Yu FS, et al. UBIAD1 mutation alters a mitochondrial prenyltransferase to cause Schnyder corneal dystrophy. PLoS One. 2010;5:e10760. CrossRef
Nowinska AK, Wylegala E, Teper S, Lyssek-Boron A, Aragona P, Roszkowska AM, et al. Phenotype-genotype correlation in patients with Schnyder corneal dystrophy. Cornea. 2014;33:497–503. CrossRef
Al-Ghadeer H, Mohamed JY, Khan AO. Schnyder corneal dystrophy in a Saudi Arabian family with heterozygous UBIAD1 mutation (p.L121F). Middle East Afr J Ophthalmol. 2011;18:61–4. CrossRef
Weiss JS, Khemichian AJ. Differential diagnosis of Schnyder corneal dystrophy. Dev Ophthalmol. 2011;48:67–96. CrossRef
Vesaluoma MH, Linna TU, Sankila EM, Weiss JS, Tervo TM. In vivo confocal microscopy of a family with Schnyder crystalline corneal dystrophy. Ophthalmology. 1999;106:944–51. CrossRef
Rodrigues MM, Kruth HS, Krachmer JH, Willis R. Unesterified cholesterol in Schnyder’s corneal crystalline dystrophy. Am J Ophthalmol. 1987;104:157–63. CrossRef
Rodrigues MM, Kruth HS, Krachmer JH, et al. Cholesterol localization in ultrathin frozen sections in Schnyder’s corneal crystalline dystrophy. Am J Ophthalmol. 1990;110:513–7. CrossRef
Kohnen T, Pelton RW, Jones DB. Schnyder corneal dystrophy and juvenile, systemic hypercholesteremia. Klin Monatsbl Augenheilkd. 1997;211:135–7. CrossRef
- Schnyder corneal dystrophy and associated phenotypes caused by novel and recurrent mutations in the UBIAD1 gene
Cerys J. Evans
Alison J. Hardcastle
Stephen J. Tuft
- BioMed Central